- Trials with a EudraCT protocol (45)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
45 result(s) found for: Mesenteric.
Displaying page 1 of 3.
EudraCT Number: 2014-005162-29 | Sponsor Protocol Number: RivaSVT100 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:A.O. OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI | |||||||||||||
Full Title: Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study | |||||||||||||
Medical condition: Portal, mesenteric, and splenic vein thrombosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003669-17 | Sponsor Protocol Number: NEOPA | Start Date*: 2013-12-17 | |||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma (NEOPA). | |||||||||||||
Medical condition: Non-metastasized, adenocarcinoma of the pancreatic head/uncinate process or body of pancreas that was treated with extended pancreatic head/body resection larger than 2 cm in size (≥cT2) and/or in ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002910-39 | Sponsor Protocol Number: NC19453 | Start Date*: 2006-07-31 |
Sponsor Name:F. Hoffmann-La Roche Ltd. | ||
Full Title: A Phase II, Double-Blind, Randomized, Placebo-controlled, Parallel Group Study, Evaluating the Efficacy and Safety of RO4607381 over a 24-week period in Patients with CHD or a CHD Risk Equivalent | ||
Medical condition: CHD or CHD Risk Equivalent | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004446-29 | Sponsor Protocol Number: LIBERAL-Trial | Start Date*: 2017-10-30 | |||||||||||
Sponsor Name:University Hospital Wuerzburg, Institution under public law, represented by the Medical Director | |||||||||||||
Full Title: Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients | |||||||||||||
Medical condition: Elderly patients (>= 70 years) undergoing intermediate- or high-risk non-cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004987-91 | Sponsor Protocol Number: 2020/ABM/01/00098 | Start Date*: 2021-11-17 | |||||||||||
Sponsor Name:Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu | |||||||||||||
Full Title: Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic can... | |||||||||||||
Medical condition: Unresectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005499-16 | Sponsor Protocol Number: 2013-624 | Start Date*: 2014-01-31 | |||||||||||||||||||||
Sponsor Name:Rigshospitalet, 2121 | |||||||||||||||||||||||
Full Title: Pilot Study with Treatment of Short Bowel Syndrome Patients with end-jejunostomi with the Glucagon-Like Peptide-1 analogue, Liraglutide (Victoza®) | |||||||||||||||||||||||
Medical condition: Short Bowel Syndrome with intestinal failure (SBS IF) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-002196-34 | Sponsor Protocol Number: Neo.Lu.Pa.NET | Start Date*: 2019-11-07 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: A Prospective Phase II Single-Arm Trial on Neoadjuvant Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Followed by Surgery for resectable Pancreatic Neuroendocrine Tumors (Neo.Lu.Pa.NET) | |||||||||||||
Medical condition: Resectable pancreatic neuroendocrine tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000345-46 | Sponsor Protocol Number: CRC2017_01 | Start Date*: 2017-11-22 | |||||||||||
Sponsor Name:CENTRO RICERCHE CLINICHE DI VERONA | |||||||||||||
Full Title: A Phase II Study of Liposomial IrinoTecan (nal-IRI) with 5-Fluorouracil, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer ¿nITRo trial" | |||||||||||||
Medical condition: Resectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001472-18 | Sponsor Protocol Number: UDT-2/PHT | Start Date*: 2011-05-10 |
Sponsor Name:STZ 1172 Gesundheitsförderung und Stoffwechselforschung | ||
Full Title: Double-Blind, Randomised, Cross-Over, Placebo-Controlled, Single-Centre Phase IIa Clinical Study on the Influence of Udenafil on the Portal Flow in Cirrhotic Patients with Portal Hypertension | ||
Medical condition: Portal hypertension, liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001697-58 | Sponsor Protocol Number: 2128/2021 | Start Date*: 2022-12-20 |
Sponsor Name:Medical University of Vienna | ||
Full Title: An investigation of clinical outcomes and inflammatory response to heparin free extracorporeal membrane oxygenation support during clinical lung transplantation – a prospective double-blind randomi... | ||
Medical condition: Intraoperative extra-corporeal membrane oxygenation during lung transplantation for end-stage lung disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003240-37 | Sponsor Protocol Number: TROMBOXABAN | Start Date*: 2017-02-20 |
Sponsor Name:Fundación para la Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Prospective, multicenter, randomized study to assess the effect of rivaroxaban in the portal vein thrombosis recanalization and the survival in patients with cirrhosis and portal vein thrombosis | ||
Medical condition: Liver cirrhosis and portal vein thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002323-15 | Sponsor Protocol Number: PREPOSTEROUS | Start Date*: 2021-12-10 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Pre- vs. postoperative thromboprophylaxis for liver resection – a prospective, multicenter, randomized controlled trial | ||
Medical condition: Venous thromboembolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000087-26 | Sponsor Protocol Number: 2019/09 | Start Date*: 2020-04-16 | |||||||||||||||||||||
Sponsor Name:CMC AMBROISE PARE | |||||||||||||||||||||||
Full Title: Time to transit Recovery After treatment with Naloxegol in cardiac Surgery Intensive care Trial | |||||||||||||||||||||||
Medical condition: ileus after cardiac surgery | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001028-21 | Sponsor Protocol Number: ABCSG_P01 | Start Date*: 2013-05-17 | |||||||||||
Sponsor Name:ABCSG (Austrian Breast & Colorectal Cancer Study Group) | |||||||||||||
Full Title: P01 - A prospective, randomized, multicenter trial of additional radiochemotherapy to neoadjuvant chemotherapy in patients with locally advanced pancreatic adenocarcinoma | |||||||||||||
Medical condition: locally advanced pancreatic adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000236-26 | Sponsor Protocol Number: CRLX030X2201 | Start Date*: 2012-11-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An exploratory study to investigate the haemodynamic effects of serelaxin in patients with compensated cirrhosis and portal hypertension | |||||||||||||
Medical condition: Compensated alcohol-related cirrhosis and portal hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002253-30 | Sponsor Protocol Number: SVT-RUXO#2012 | Start Date*: 2012-10-04 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI FIRENZE | |||||||||||||
Full Title: A phase 2 study of Ruxolitinib in patients with splanchnic vein thrombosis associated with myeloproliferative neoplasm | |||||||||||||
Medical condition: splanchnic vein thrombosis associated with myeloproliferative neoplasm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001620-33 | Sponsor Protocol Number: APHP200033 | Start Date*: 2021-01-13 |
Sponsor Name:ASSISTANCE-PUBLIQUE HOPITAUX DE PARIS (AP-HP) | ||
Full Title: HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome | ||
Medical condition: Adult cardiac arrest patients with sustained ROSC and hemodynamic failure due to post-resuscitation syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000505-39 | Sponsor Protocol Number: CHUBX2014/13 | Start Date*: 2015-03-19 | |||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||
Full Title: The role of dexchlorpheniramine (Polaramine®) to prevent hemodynamic instability after separation from cardiopulmonary bypass during cardiac surgery. | |||||||||||||
Medical condition: vasoplegic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003391-39 | Sponsor Protocol Number: 9026 | Start Date*: 2012-10-26 | |||||||||||
Sponsor Name:University Hospital of Montpellier | |||||||||||||
Full Title: Ballon aortic valvuloplasty performed without heparin to decrease vascular and bleeding complications of the procedure | |||||||||||||
Medical condition: Aortic stenosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000401-76 | Sponsor Protocol Number: 7715 | Start Date*: 2019-11-26 |
Sponsor Name:University hospital of Montpellier | ||
Full Title: Transfusion savings in heart surgery: impact of individual strategy, optimized by erythropoietin (EPO) and metabolic adjustment (ScvO2) | ||
Medical condition: Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
